Harry Peterson
0
All posts from Harry Peterson
Harry Peterson in Investing & more!,

Investors in health-care stocks get rich as M&A booms

Deal premiums rise as takeover battles become common

Shutterstock

Health-care M&A is on fire, with 23 of 36 takeout deals totaling more than $100 million each since the beginning of 2014.

Valeant Pharmaceuticals’ winning takeout bid for Salix Pharmaceuticals sheds light on other potential windfalls for investors as health-care companies feel the urge to merge.

Valeant VRX, -0.02% raised its cash offer for Salix SLXP, -0.16% to $173 from $158 a share, trumping a rival cash-and-stock bid of $172.50 a share from Endo International ENDP, +1.26%

ENDP, +1.26% Valeant’s original bid for Salix, which makes medications to treat digestive problems, was accepted by Salix on Feb. 20, and the original $158 offer represented a 27% premium over its closing share price 30 days earlier and a 54% premium over the closing price 90 days earlier.

It’s useful to look that far back when considering M&A premiums, because takeout rumors tend to drive stock prices up during the days leading up to deal announcements.

There have been 36 health-care M&A deals with values exceeding $100 million since the beginning of 2014, according to FactSet.

Here are the 10 announced deals with the highest premiums based on closing share prices 30 days before the agreement date:

AcquirerAcquirer tickerTargetDeal statusDeal value ($mil)30-day premium90-day premium
Daiichi Sankyo Co.N/AAmbit Biosciences Corp.Complete$298141%144%
Teva Pharmaceutical Industries Ltd.TEVA,+0.16%NuPathe Inc.Complete$225116%38%
Kindred Healthcare Inc.KND,-1.41%Gentiva Health Services Inc.Complete$1,826105%65%
Owens & Minor Inc.OMI,-0.12%Medical Action Industries Inc.Complete$280101%76%
Royal Philips NVPHIA,-1.02% Volcano Corp.Complete$1,17281%49%
Actavis PLCACT,+0.32%Durata Therapeutics Inc.Complete$77975%82%
Endo International PLCENDP,+1.26%Auxilium Pharmaceuticals Inc.Complete$2,33973%20%
AbbVie Inc.ABBV,+0.02%Pharmacyclics Inc.Pending$19,04573%115%
Actavis PLCACT,+0.32%Allergan Inc.Pending$65,91569%125%
Roche Holding AGRO,-0.56%InterMune Inc.Complete$7,68968%161%
Source: FactSet


http://www.marketwatch.com/story/investors-in-health-care-st...